Topics

FDA Approves Lannett’s NDA For Branded Anesthetic Product, Cocaine Hydrochloride Nasal Solution

14:10 EST 15 Jan 2020 | Speciality Pharma Journal

PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ — Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA), submitted under the 505(b)(2) regulatory pathway, for Cocaine Hydrochloride (HCl) Nasal Solution 4% (40 mg/mL), the company’s branded local anesthetic product.  “The FDA’s approval of our Cocaine HCl product, …

Original Article: FDA Approves Lannett’s NDA For Branded Anesthetic Product, Cocaine Hydrochloride Nasal Solution

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Lannett’s NDA For Branded Anesthetic Product, Cocaine Hydrochloride Nasal Solution"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...